Bird Flu Market Expected to Reach 2.17 Billion USD by 2031 Driven by Rising Poultry Consumption and Increasing Government Investments in Avian Influenza Control

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bird Flu Market - (By Virus Type (H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, Others), By Test Type (PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, Others), By Treatment Type (Vaccines, Antiviral Medication, Immunomodulators, Others), By Animal Type (Chickens, Ducks, Geese & Swans, Pigeons, Guinea Fowls, Turkeys, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Bird Flu Market is valued at US$ 1.41 Bn in 2023, and it is expected to reach US$ 2.17 Bn by 2031, with a CAGR of 5.82% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2347

Avian Influenza, commonly known as bird flu, primarily affects avian species but has also demonstrated the capability to infect humans and other animals. Although it shares similarities with the influenza viruses responsible for seasonal flu in humans, bird flu tends to be significantly more virulent among bird populations. Increased government investment in the development of effective treatment options, coupled with the rising mortality rate of birds due to various viral infections, is anticipated to drive growth in the global bird flu market. The dynamics of this market are shaped by several critical factors, including the emergence of novel viral strains, evolving poultry farming practices, international trade activities, and advancements in healthcare technologies. Although human infection cases remain relatively rare, the potential threat of a widespread outbreak and the consequential disruption to the poultry industry underscore the importance of sustained public health preparedness and economic risk mitigation.

List of Prominent Players in the Bird Flu Market
• Boehringer Ingelheim
• Ceva Santé Animale
• Zoetis
• Merck & Co.
• Ringpu Biology
• Yebio Bioengineering
• FATRO
• CAVAC
• ChengDu Tecbond
• QYH Biotech
• Elanco
• Phibro Animal Health
• Vetoquinol
• Hipra
• Venkys
• Anicon Labor GmbH
• Bioveta
• Lohmann Animal Health
• Biogenesis Bago
• Sanofi
• F. Hoffmann-La Roche Ltd.
• Mallinckrodt
• GlaxoSmithKline plc
• Novartis AG
• Bayer AG
• Eli Lilly and Company
• AstraZeneca
• Johnson & Johnson Private Limited
• Bimeda, Inc.
• Phibro Animal Health Corporation
• Medion
• Other prominent players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The global demand for animal protein-particularly pork, poultry, and other meat products-has grown substantially in recent decades, largely due to rapid population growth. This increase in livestock populations has heightened the vulnerability of certain species, especially chickens and ducks, to viral infections such as avian influenza. Migratory wild birds-including ducks, geese, and shorebirds-as well as domesticated poultry, play a central role in the ecological cycle of bird flu viruses. These migratory species often travel long distances during seasonal movements, potentially spreading the virus over large geographical areas. Surveillance data collected from wild bird populations is instrumental in shaping disease management strategies and conducting comprehensive risk assessments.

Challenges:
One of the major obstacles in combating avian influenza lies in societal resistance to control measures. Mass culling of infected birds, a common strategy during outbreaks, can result in significant financial losses for poultry farmers, leading to opposition from affected communities. Additionally, skepticism toward vaccines and other preventative methods, often fueled by misinformation, further complicates disease control efforts. Tracking the source of outbreaks is also challenging, particularly due to the unregulated and sometimes illegal trade of live poultry, especially in traditional wet markets. Furthermore, the high cost associated with vaccine development-including extensive research, regulatory approval processes, clinical trials, and testing-acts as a barrier to the expansion of the bird flu prevention market.

Regional Trends:
North America currently leads in the development and implementation of bird flu prevention and control strategies. The region hosts several prominent manufacturers of diagnostic tools and vaccines, particularly in the United States. The presence of extensive poultry industries in both the U.S. and Canada necessitates rigorous biosecurity measures in commercial poultry operations, driven by stringent food safety regulations.

Asia Pacific, on the other hand, is the fastest-growing region in terms of bird flu management. Countries such as China, India, and Vietnam have some of the highest rates of poultry production and consumption, which increases their susceptibility to avian influenza outbreaks-often introduced by migratory bird populations. This heightened risk is accelerating the adoption of surveillance, vaccination, and containment efforts across the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2347

Recent Developments:
• In July 2023, The vaccination campaign scheduled to commence in October 2023 in France chosen Boehringer Ingelheim, a German company, to supply the required quantity of 80 million doses of avian influenza vaccines. By commencing this campaign, France achieved the distinction of being the inaugural member state of the European Union to immunize poultry against avian influenza. Positive test results for vaccines manufactured in France by Ceva Animal Health and Boehringer Ingelheim were reported by officials of the Ministry of Agriculture last month.

Segmentation of Bird Flu Market -
By Virus Type:
• H5N1
• H7N9
• H5N6
• H5N8
• H10N8
• H9N2
• Others
By Test Type:
• PCR Tests
• ELISA Tests
• Hemagglutination Assays
• Virus Isolation Tests
• Next Generation Sequencing
• Others
By Treatment Type:
• Vaccines
• Antiviral Medication
• Immunomodulators
• Others
By Animal Type:
• Chickens
• Ducks
• Geese & Swans
• Pigeons
• Guinea Fowls
• Turkeys
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.